80 related articles for article (PubMed ID: 3660987)
21. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
[TBL] [Abstract][Full Text] [Related]
22. The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor.
Loring M; Schlesinger M
Cancer Res; 1970 Aug; 30(8):2204-7. PubMed ID: 5466693
[No Abstract] [Full Text] [Related]
23. Immunologic control of the ascites form of murine adenocarcinoma 755. III. Efficacy of serum therapy is controlled by a single genetic locus.
Roloson GJ; Haagensen DE; Chambers CA; Bolognesi DP
J Immunol; 1981 Jun; 126(6):2328-31. PubMed ID: 7229376
[TBL] [Abstract][Full Text] [Related]
24. Scanning electron microscopy of contactual interaction of sensitized lymphocytes with homologous target cells.
Orita K; Yamamoto I; Murakami T
Acta Med Okayama (1952); 1971 Oct; 25(5):525-36. PubMed ID: 4264431
[No Abstract] [Full Text] [Related]
25. Leukemoid reaction induced by different transplantable tumors in three inbred mouse strains.
Castillo R; Díaz JW; Veloso A; Gavilondo J
Neoplasma; 1982; 29(1):73-9. PubMed ID: 7070557
[TBL] [Abstract][Full Text] [Related]
26. Resistance and susceptibility to tumours. 3. Effect of some derivatives from immunized animals on the Bo4 and Ehrlich carcinomas.
Dvorák R; Chlumecký J
Neoplasma; 1969; 16(6):613-24. PubMed ID: 5369028
[No Abstract] [Full Text] [Related]
27. [An experiment in the use of vital dye staining of cells for study of the cancerolytic properties of the blood of oncological patients].
Brumberg IE
Tsitologiia; 1966; 8(6):772-4. PubMed ID: 4166638
[No Abstract] [Full Text] [Related]
28. [Production of heterologous antibodies to T-killers of mice immunized against H-2 antigens].
Egorova SG; Gritsman AIu; Brondz BD
Biull Eksp Biol Med; 1980 Jul; 89(7):62-4. PubMed ID: 6157432
[TBL] [Abstract][Full Text] [Related]
29. [Immunoglobulins from a tumor-bearing body as possible regulators of the growth rate of relapses and metastases of Ehrlich carcinoma].
Donenko FV; Moroz LV
Biull Eksp Biol Med; 1995 Jan; 119(1):62-4. PubMed ID: 7718807
[No Abstract] [Full Text] [Related]
30. [Cells of various types activated in vitro by phytohemagglutinin. Target cell lysis].
Roveta G; Pagani G
Boll Soc Ital Biol Sper; 1973 Apr; 49(7):357-61. PubMed ID: 4361896
[No Abstract] [Full Text] [Related]
31. [Antitumor activity and immune response induced by the vaccine of Venezuelan encephalomyelitis].
Gromova AIu
Vopr Onkol; 1997; 43(6):639-44. PubMed ID: 9479368
[No Abstract] [Full Text] [Related]
32. Systemic immunologic stimuli increase class I and II antigen expression in mouse kidney.
Halloran PF; Jephthah-Ochola J; Urmson J; Farkas S
J Immunol; 1985 Aug; 135(2):1053-60. PubMed ID: 3891851
[TBL] [Abstract][Full Text] [Related]
33. Specific depletion of GVH reactivity of mouse lymphocytes by adsorption on allogeneic fibroblast monolayers.
Lonai P; Eliraz A; Wekerle H; Feldman M
Transplant Proc; 1973 Mar; 5(1):857-9. PubMed ID: 4144465
[No Abstract] [Full Text] [Related]
34. Reversibility of the immunodepression due to Ehrlich ascites carcinoma.
Mocarelli P; Villa ML; Garotta G; Porta C; Bigi G; Clerici E
J Immunol; 1973 Sep; 111(3):973-5. PubMed ID: 4582265
[No Abstract] [Full Text] [Related]
35. The effect of the Ehrlich ascitic fluid on the in vitro polyclonal differentiation of murine lymphocytes.
Olinescu A; Hristescu S
Arch Roum Pathol Exp Microbiol; 1982; 41(2):157-65. PubMed ID: 7149962
[No Abstract] [Full Text] [Related]
36. Immunosuppressive effect of mouse serum lipoproteins. I. In vitro studies.
Hsu KH; Ghanta VK; Hiramoto RN
J Immunol; 1981 May; 126(5):1909-13. PubMed ID: 7217673
[TBL] [Abstract][Full Text] [Related]
37. [Reduced antitumoral and suppressor activity of nonadherent bone marrow cells during culturing in a mixture with supernatant of Ehrlich tumor].
Bel'skiĭ IuP; Agranovich IM; Kusmartsev SA
Biull Eksp Biol Med; 1994 May; 117(5):514-7. PubMed ID: 9296706
[No Abstract] [Full Text] [Related]
38. [Histochemical studies on the effect of antibody and serum factors on ascites tumor cells and mast cells].
Keller R
Bibl Haematol; 1967; 27():95-101. PubMed ID: 4233209
[No Abstract] [Full Text] [Related]
39. [Studies on fluorescence polarization of human blood lymphocytes (SCM test) using a Percoll gradient centrifugal separation method].
Tenzaki T; Matsumoto J; Ishiguro T; Yoshida Y; Sugiyama S
Rinsho Byori; 1984 Apr; 32(4):394-8. PubMed ID: 6088848
[No Abstract] [Full Text] [Related]
40. Cellular antibody in mice bearing Ehrlich cancer. 3. Relationship of cellular antibody to serum antibody.
Hara S
Acta Med Okayama (1952); 1965 Dec; 19(6):279-86. PubMed ID: 4223615
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
